SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-008074
Filing Date
2020-03-30
Accepted
2020-03-30 17:31:35
Documents
84
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2019_wizepharmainc.htm 10-K 1597529
2 CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES B NON-VOTING REDEE f10k2019ex3-6_wizepharma.htm EX-3.6 47666
3 DESCRIPTION OF SECURITIES f10k2019ex4-3_wizepharma.htm EX-4.3 23844
4 MEMORANDUM OF UNDERSTANDING BETWEEN WIZE PHARMA LTD. AND RESDEVCO, RESEARCH AND f10k2019ex10-55_wizepharma.htm EX-10.55 620
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2019ex23-1_wizepharma.htm EX-23.1 4050
6 CERTIFICATION f10k2019ex31-1_wizepharma.htm EX-31.1 14913
7 CERTIFICATION f10k2019ex31-2_wizepharma.htm EX-31.2 11525
8 CERTIFICATION f10k2019ex32-1_wizepharma.htm EX-32.1 5251
9 CERTIFICATION f10k2019ex32-2_wizepharma.htm EX-32.2 5495
10 GRAPHIC img_01.jpg GRAPHIC 11822
17 GRAPHIC ex23-1_001.jpg GRAPHIC 5176
18 GRAPHIC ex1055.jpg GRAPHIC 475411
  Complete submission text file 0001213900-20-008074.txt   6639270

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE wizp-20191231.xml EX-101.INS 924545
12 XBRL SCHEMA FILE wizp-20191231.xsd EX-101.SCH 72022
13 XBRL CALCULATION FILE wizp-20191231_cal.xml EX-101.CAL 46542
14 XBRL DEFINITION FILE wizp-20191231_def.xml EX-101.DEF 203459
15 XBRL LABEL FILE wizp-20191231_lab.xml EX-101.LAB 408876
16 XBRL PRESENTATION FILE wizp-20191231_pre.xml EX-101.PRE 323184
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52545 | Film No.: 20758625
SIC: 2834 Pharmaceutical Preparations